AKAM vs TVRD · P/E 27, rev $2.17B vs rev $2.6M
Akamai Technologies Inc (AKAM) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. TVRD currently screens at market cap $0.
Not investment advice. Open the AKAM and TVRD stock pages for the full models.
Not investment advice.